TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant treatment of patients with stage IIB-III resectable microsatellite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback